Myocardial dysfunction in donor hearts. A possible etiology.

BACKGROUND Potential cardiac donors show various degrees of myocardial dysfunction, and the most severely affected hearts are unsuitable for transplantation. The cause of this acute heart failure is poorly understood. We investigated whether alterations in calcium-handling proteins, beta-adrenoceptor density, or the inhibitory G protein Gialpha could account for this phenomenon in unused donor hearts (n=4 to 8). We compared these with end-stage failing hearts (n=14 to 16) and nonfailing hearts (n=3 to 12). METHODS AND RESULTS Myocardial samples were obtained from unused donor hearts displaying ejection fractions <30%. Both trabeculae and isolated myocytes responded as poorly as those from the group of failing hearts to increasing stimulation frequency with regard to inotropic function in vitro. Immunodetectable abundance of sarcoplasmic reticulum calcium-ATPase and sodium calcium exchanger were greater (177%; P<0.01) and smaller (29%; P<0.01), respectively, in the unused donor hearts relative to the failing group, which suggests that alterations of these proteins are not a common cause of contractile dysfunction in the 2 groups. Myocytes from the unused donor group were desensitized to isoprenaline to a similar degree as those from the failing heart group. However, beta-adrenoceptor density was reduced in the failing (P<0.001) but not in the unused donor heart group (P=0.37) relative to the nonfailing heart group (n=5). Gialpha activity was increased in samples from unused donor and failing hearts relative to nonfailing hearts (P<0.05). CONCLUSIONS Increased activity of the inhibitory G protein Gialpha is a significant contributory factor for impaired contractility in these acutely failing donor hearts.

[1]  W. Schmitz,et al.  Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human hearts. , 1996, Cardiovascular research.

[2]  M. Yacoub,et al.  Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development. , 1999, European heart journal.

[3]  F. del Monte,et al.  From overload to failure: what happens inside the myocyte. , 1998, Annals of medicine.

[4]  R. Schwinger,et al.  Unchanged protein expression of sarcoplasmic reticulum Ca2+-ATPase, phospholamban, and calsequestrin in terminally failing human myocardium , 1998, Journal of Molecular Medicine.

[5]  G Arnold,et al.  Evidence for functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in failing human myocardium. , 1996, Circulation.

[6]  F. Müller,et al.  Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human hearts. , 1996, Cardiovascular research.

[7]  H. Drexler,et al.  Cardiac Na+/Ca2+ exchange activity in patients with end-stage heart failure. , 1996, Cardiovascular research.

[8]  C H Davies,et al.  Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. , 1995, Circulation.

[9]  J. Port,et al.  Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage. , 1995, Circulation.

[10]  M. Böhm,et al.  Myocardial Giα-protein levels in patients with hypertensive cardiac hypertrophy, ischemic heart disease and cardiogenic shock , 1995 .

[11]  R. Novick,et al.  The Registry of the International Society for Heart and Lung Transplantation: twelfth official report--1995. , 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  H. Drexler,et al.  Relation between myocardial function and expression of sarcoplasmic reticulum Ca(2+)-ATPase in failing and nonfailing human myocardium. , 1994, Circulation research.

[13]  H. Drexler,et al.  Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure. , 1994, Circulation research.

[14]  M. Movsesian,et al.  Ca(2+)-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. , 1994, Circulation.

[15]  M. Steinfath,et al.  Radioimmunochemical quantification of Gi alpha in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure. , 1994, Journal of molecular and cellular cardiology.

[16]  N. Alpert,et al.  Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. , 1993, Circulation research.

[17]  Kaye Mp The Registry of the International Society for Heart and Lung Transplantation: tenth official report--1993. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  J. Schulte am Esch,et al.  Long term beta-adrenoceptor-mediated up-regulation of Gi alpha and G(o) alpha mRNA levels and pertussis toxin-sensitive guanine nucleotide-binding proteins in rat heart. , 1992, Molecular pharmacology.

[19]  S. Harding,et al.  The effect of pertussis toxin on β‐adrenoceptor responses in isolated cardiac myocytes from noradrenaline‐treated guinea‐pigs and patients with cardiac failure , 1992, British journal of pharmacology.

[20]  N. Alpert,et al.  Altered Myocardial Force‐Frequency Relation in Human Heart Failure , 1992, Circulation.

[21]  D. Renlund,et al.  Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. , 1991, Circulation.

[22]  P. Poole‐Wilson,et al.  A comparison of contractile function between papillary muscles and isolated myocytes from the same human hearts. , 1991, Cardioscience.

[23]  B. Lewartowski,et al.  Net Ca2+ influx and sarcoplasmic reticulum Ca2+ uptake in resting single myocytes of the rat heart: comparison with guinea-pig. , 1990, Journal of molecular and cellular cardiology.

[24]  K. Jakobs,et al.  Mechanism of noradrenaline-induced heterologous desensitization of adenylate cyclase stimulation in rat heart muscle cells: increase in the level of inhibitory G-protein alpha-subunits. , 1989, European journal of pharmacology.

[25]  M. Michel,et al.  Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. , 1989, Journal of the American College of Cardiology.

[26]  W. Baumgartner,et al.  Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. , 1988, The Journal of clinical investigation.